ContextMedia:Health, the leading provider of digital solutions at the point of care, today announced the launch of a content development partnership with the Heart Rhythm Society (HRS), the country's leading resource on heart rhythm disorders. The partnership will bring content from the HRS educational library to patients in ContextMedia:Health's network of 25,000 practices by way of ContextMedia:Health's suite of digital waiting room and exam room platforms.
The mid to long-term results from the EFFORTLESS study, the largest subcutaneous implantable cardioverter-defibrillator (S-ICD) registry in the world, show the device provides reliable treatment for ventricular tachyarrhythmias. This is the first report on the fully enrolled EFFORTLESS cohort and includes real-world outcomes of almost 1,000 patients implanted with an S-ICD. Positive results showing longevity during three- and up to five-year follow-ups were presented today at Heart Rhythm 2016, the Heart Rhythm Society’s 37th Annual Scientific Sessions.
A new study shows the use of novel anticoagulants (such as rivoraxiban, apixiban and dabigatran) to treat atrial fibrillation (AF) on an “as needed basis” guided by diligent pulse monitoring can be an effective and safe way to lower overall risk of stroke. The study includes motivated patients that were eager to seek an alternative to long-term, daily oral anticoagulation therapy (OAT) after ablation or drug therapy. The research was presented today at Heart Rhythm 2016, the Heart Rhythm Society’s 37th Annual Scientific Sessions.